malondialdehyde has been researched along with ginsenoside rg3 in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, SR; Kim, YC; Markelonis, GJ; Oh, TH | 1 |
Fu, F; Geng, M; Jiang, W; Jiang, Y; Liu, K; Tian, J; Wang, C; Yang, J | 1 |
Duan, L; Wu, CF; Yang, JY; Zhang, QH | 1 |
Hu, S; Hu, T; Su, F; Su, X; Wei, X | 1 |
Fang, X; Jia, C; Li, J; Liu, T; Peng, YF; Tao, X; Yang, BH | 1 |
Lai, XD; Ouyang, J; Yang, JD; Yang, QY | 1 |
6 other study(ies) available for malondialdehyde and ginsenoside rg3
Article | Year |
---|---|
Ginsenosides Rb1 and Rg3 protect cultured rat cortical cells from glutamate-induced neurodegeneration.
Topics: Animals; Calcium; Cell Survival; Cells, Cultured; Cerebral Cortex; Fetus; Ginsenosides; Glutamic Acid; Lipid Peroxidation; Malondialdehyde; Nerve Degeneration; Neurons; Neurotoxins; Panax; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Saponins; Superoxide Dismutase | 1998 |
Neuroprotective effect of 20(S)-ginsenoside Rg3 on cerebral ischemia in rats.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Brain Chemistry; Brain Ischemia; Calcium Channel Blockers; Cerebral Infarction; Disease Models, Animal; Dose-Response Relationship, Drug; Ginsenosides; Glutathione Peroxidase; Infarction, Middle Cerebral Artery; Male; Malondialdehyde; Mitochondria; Neurologic Examination; Neuroprotective Agents; Nimodipine; Rats; Rats, Inbred WKY; Superoxide Dismutase; Time Factors | 2005 |
Protective effects of ginsenoside Rg(3) against cyclophosphamide-induced DNA damage and cell apoptosis in mice.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Bone Marrow Cells; Comet Assay; Cyclophosphamide; DNA Breaks; Dose-Response Relationship, Drug; Flow Cytometry; Ginsenosides; Glutathione Peroxidase; Lymphocytes; Male; Malondialdehyde; Mice; Oxidative Stress; Superoxide Dismutase | 2008 |
Stereospecific antioxidant effects of ginsenoside Rg3 on oxidative stress induced by cyclophosphamide in mice.
Topics: Animals; Antioxidants; Catalase; Cyclophosphamide; Female; Ginsenosides; Injections, Intraperitoneal; Malondialdehyde; Mice; Mice, Inbred ICR; Muramidase; Nitric Oxide; Oxidative Stress; Panax; Plant Extracts; Random Allocation; Spleen; Stereoisomerism; Superoxide Dismutase; Thymus Gland; Xanthine Oxidase | 2012 |
Ginsenoside Rg3 improves erectile function in streptozotocin-induced diabetic rats.
Topics: Actins; Animals; Caspase 3; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Erectile Dysfunction; Ginsenosides; Male; Malondialdehyde; Nitric Oxide Synthase; Penile Erection; Penis; Platelet Endothelial Cell Adhesion Molecule-1; Random Allocation; Rats; Rats, Sprague-Dawley; Streptozocin; Superoxide Dismutase | 2015 |
Effects of Ginsenoside Rg3 on fatigue resistance and SIRT1 in aged rats.
Topics: Aging; Animals; Behavior, Animal; Fatigue; Ginsenosides; HEK293 Cells; Humans; Intracellular Signaling Peptides and Proteins; Male; Malondialdehyde; Muscle, Skeletal; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphoenolpyruvate Carboxykinase (GTP); Rats, Sprague-Dawley; Sirtuin 1; Superoxide Dismutase; Tumor Suppressor Protein p53 | 2018 |